|
Volumn 279, Issue 5 23-5, 2000, Pages
|
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung
a a a a a a a a a a |
Author keywords
Alveolar macrophage; Bleomycin; Chronic obstructive pulmonary disease; Interleukin 6; Matrix metalloproteinase 9; Mitogen activated protein kinase
|
Indexed keywords
1 (4 HYDROXYCYCLOHEXYL) 4 (4 FLUOROPHENYL) 5 (2 METHOXYPYRIDIMIDIN 4 YL)IMIDAZOLE;
4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL;
CYTOKINE;
GELATINASE B;
INTERLEUKIN 6;
LIPOPOLYSACCHARIDE;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DOSE RESPONSE;
DRUG EFFECT;
ENZYME ACTIVITY;
GUINEA PIG;
HEART RIGHT VENTRICLE HYPERTROPHY;
LUNG FIBROSIS;
LUNG INFILTRATE;
LUNG LAVAGE;
MALE;
NEUTROPHILIA;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
|
EID: 13844288120
PISSN: 10400605
EISSN: None
Source Type: Journal
DOI: 10.1152/ajplung.2000.279.5.l895 Document Type: Article |
Times cited : (297)
|
References (31)
|